SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-255706
Filing Date
2011-09-26
Accepted
2011-09-26 06:18:28
Documents
4
Period of Report
2011-09-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d236172d8k.htm 8-K 20864
2 REVISED DIRECTOR COMPENSATION POLICY d236172dex101.htm EX-10.1 10595
3 PRESS RELEASE d236172dex991.htm EX-99.1 11915
4 GRAPHIC g236172image-001.jpg GRAPHIC 2227
  Complete submission text file 0001193125-11-255706.txt   47852
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 111106266
SIC: 2834 Pharmaceutical Preparations